At present, the prevalent oral solid dosage forms, the capsules and tablets, are loose or lightly compacted mixtures of drug ...

Chemistry is at the centre of our existence and offers transformative solutions to many global challenges, including health. RSC Pharmaceutics acknowledges how chemistry and related disciplines can ...

ZURICH, SWITZERLAND / ACCESSWIRE / June 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the ...

Six faculty members from the NIPER Guwahati have been recognized as part of Stanford University's prestigious list.

In this regard the perspectives of packaging development are closely connected with the need for the increasing efficiency of this field that should make packaging more intelligent and ready for ...

GD-iExo-003 is under clinical development by Guidon Pharmaceutics and currently in Phase I for Acute Ischemic Stroke. According to GlobalData, Phase I drugs for Acute Ischemic Stroke have an 86% phase ...

Quotient Sciences, Vasa Therapeutics dose first human subjects with VS-041, a novel therapy for heart failure with preserved ejection fraction: Nottingham, UK Monday, September 16 ...

Ayurveda offers several wonderful herbs that benefit your skin, hair and overall health. One herb that can work wonders for ...

Lecturers at the Faculty of Pharmaceutical Sciences, Chulalongkorn University, have developed an alternative "Transfersome ...

北京时间2024年09月19日02时00分，居里（CRIS.us）股票出现波动，股价大幅跳水5.29%。截至发稿，该股报5.84美元/股，成交量2.9689万股，换手率0.50%，振幅6.64%。 最近的财报数据显示，该股实现营业收入2.55百万美元，净利润-11.80百万美元，每股收益-2.03美元，毛利2.47百万美元，市盈率-0.73倍。 机构评级方面，目前暂无机构对该股做出“买入、持有、卖 ...